medigraphic.com
ISSN 2007-6800 (Print)

2020, Number S2

<< Back Next >>

Rev Mex Traspl 2020; 9 (S2)

COVID-19: the challenge of prevention and effective vaccination

Sánchez-Cárdenas M, Lerma-Sánchez V, Trimiño-Monroy C, Valdés-Lagunes DA

Language: Spanish
References: 48
Page: 188-199
PDF size: 417.46 Kb.


ABSTRACT

The arrival of the SARS-CoV-2 pandemic has transformed every aspect of the global dynamics due to its great social, economic, morbidity and mortality impact. In the absence of effective treatment, having adequate preventive measures is crucial. Hand hygiene with soap and water, or with alcohol-based hand sanitizer is the simplest, low-cost and most widely used preventive measure worldwide to prevent transmission of COVID-19. On the other hand, the use of masks by health workers and non-health workers can reduce the risk of respiratory virus infection by 80 and 47% respectively. In the context of a new epidemic or pandemic, having universal access to highly effective and safe vaccination is a priority. Unfortunately, it usually takes 12 to 18 months to have vaccination available and marketable on a large scale, so taking into account learning from previous epidemics is crucial. Currently at least 10 different vaccines are already under study in humans, waiting to prove efficacy and safety.


REFERENCES

  1. Dexter HM. Using effective hand hygiene practice to prevent and control infection. Nursing Standard. 2020; 35 (5): 45-50.

  2. Pires D, Pittet D. Hand hygiene mantra: teach, monitor, improve and celebrate. J Hosp Infect. 2017; 95 (4): 335-337.

  3. Loveday HP, Wilson JA, Pratt RJ, Golsorkhi M, Tingle A, Bak A et al. Epic3: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2014; 86: S1-S70.

  4. Centers for Disease Control and Prevention. CDC Statement for Healthcare Personnel on Hand Hygiene during the Response to the International Emergence of COVID-19. 2020. Disponible en: www.cdc.gov/coronavirus/2019-ncov/hcp/hand-hygiene.html2020

  5. Treas LS, Wilkinson JM, Barnett KL, Smith MH. Basic nursing: thinking, doing, and caring. 2a. ed. Philadelphia: F. A. Davis; 2010.

  6. World Health Organization. WHO guidelines on hand hygiene in health care. 2009.

  7. Huang C, Ma W, Stack S. The hygienic efficacy of different hand-drying methods: a review of the evidence. Mayo Clin Proc. 2012; 87 (8): 791-798.

  8. Murillo-Godínez G. The Flügge’s drops. Rev Med Inst Mex Seguro Soc. 2009; 47 (3): 290.

  9. Somsen GA, van Rijn C, Kooij S, Bem RA, Bonn D. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med. 2020.

  10. Radonovich LJ, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA et al. N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA. 2019; 322 (9): 824-833.

  11. Eikenberry SE, Mancuso M, Iboi E, Phan T, Eikenberry K, Kuang Y et al. To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic. Infect Dis Model. 2020; 5: 293-308.

  12. World Health Organization. Advice on the use of masks in the context of COVID-19: interim guidance. 2020. Disponible en: https://apps.who.int/iris/handle/10665/331693

  13. Lo JY, Tsang TH, Leung YH, Yeung EY, Wu T, Lim WW. Respiratory infections during SARS outbreak, Hong Kong, 2003. Emerg Infect Dis. 2005; 11 (11): 1738-1741.

  14. Syed Q, Sopwith W, Regan M, Bellis MA. Behind the mask. Journey through an epidemic: some observations of contrasting public health responses to SARS. J Epidemiol Community Health. 2003; 57 (11): 855-856.

  15. Jefferson T, Foxlee R, Del Mar C, Dooley L, Ferroni E, Hewak B et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ. 2008; 336 (7635): 77-80.

  16. Burgess A, Horii M. Risk, ritual and health responsibilisation: Japan’s ‘safety blanket’ of surgical face mask-wearing. Sociol Health Illn. 2012; 34 (8): 1184-1198.

  17. MacIntyre CR, Cauchemez S, Dwyer DE, Seale H, Cheung P, Browne G et al. Face mask use and control of respiratory virus transmission in households. Emerg Infect Dis. 2009; 15 (2): 233-241.

  18. Liang M, Gao L, Cheng C, Zhou Q, Uy JP, Heiner K et al. Efficacy of face mask in preventing respiratory virus transmission: A systematic review and meta-analysis. Travel Med Infect Dis. 2020; 101751.

  19. Leung NHL, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, Hau BJP et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020; 26 (5): 676-680.

  20. 3M. Decontamination methods for 3M N95 respirators. Technical Bulletin; 2020 [citado el 4 de abril de 2020]. Disponible en: https://multimedia.3m.com/mws/media/1824869O/decontamination-methods-for-3m-n95- respirators-technical-bulletin.pdf

  21. Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One. 2012; 7 (4): e35797.

  22. Cook TM. Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic - a narrative review. Anaesthesia. 2020; 75 (7): 920-927.

  23. World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations [Accesado el 31de marzo de 2020]. Disponible en: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations

  24. Ağalar C, Öztürk Engin D. Protective measures for COVID-19 for healthcare providers and laboratory personnel. Turk J Med Sci. 2020; 50 (SI-1): 578-584.

  25. Centers for Diseases Control and Prevention. Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html

  26. BSI group. Respiratory protective devices. Filtering half masks to protect against particles. Requirements, testing, marking. 2020 [Accesado el 28 de marzo de 2020]. Available in: https://www.bsigroup.com/en-GB/topics/novel-coronavirus-covid-19/medical-devices-ppe/

  27. NIOSH Guide to the Selection and Use of Particulate Respirators. 2020 [Access 26/3/2020]. Disponible en: https://www.cdc.gov/niosh/docs/96-101/default.html

  28. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? a review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020; 28 (3): 391-395.

  29. van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382 (16): 1564-1567.

  30. Cohen J. Vaccine designers take first shots at COVID-19. Science. 2020; 368 (6486): 14-16.

  31. Billington J, Deschamps I, Erck SC et al. Developing vaccines for SARS-CoV-2 and future epidemics and pandemics: applying lessons from past outbreaks. Health Secur. 2020.

  32. Hirzel C, Kumar D. Influenza vaccine strategies for solid organ transplant recipients. Curr Opin Infect Dis. 2018; 31 (4): 309-315.

  33. Kumar D, Campbell P, Hoschler K, Hidalgo L, Al-Dabbagh M, Wilson L et al. Randomized controlled trial of adjuvanted versus nonadjuvanted influenza vaccine in kidney transplant recipients. Transplantation. 2016; 100 (3): 662-669.

  34. Cordero E, Roca-Oporto C, Bulnes-Ramos A et al. Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1-2, a randomized controlled clinical trial. Clin Infect Dis. 2017; 64 (7): 829-838.

  35. Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020; 580 (7805): 576-577.

  36. Shang W, Yang Y, Rao Y, Rao X. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. NPJ Vaccines. 2020; 5: 18.

  37. Pronker ES, Weenen TC, Commandeur H, Claassen EH, Osterhaus AD. Risk in vaccine research and development quantified. PLoS One. 2013; 8 (3): e57755.

  38. Decaro N, Martella V, Saif LJ, Buonavoglia C. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us. Res Vet Sci. 2020; 131: 21-23.

  39. Fung TS, Liu DX. Human Coronavirus: Host-Pathogen Interaction. Annu Rev Microbiol. 2019; 73: 529-557.

  40. Adams ER, Anand R, Andersson MI, Auckland K, Baillie JK, Barnes E et al. Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays. medRxiv. 2020.

  41. Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP et al. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005. Vaccine. 2009; 27 (17): 2335-2341.

  42. Natori Y, Shiotsuka M, Slomovic J et al. A Double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients. Clin Infect Dis. 2018; 66 (11): 1698-1704.

  43. D’Arienzo M, Coniglio A. Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy. Biosaf Health. 2020.

  44. Ridenhour B, Kowalik JM, Shay DK. Unraveling R₀: considerations for public health applications. Rev Panam Salud Publica. 2015; 38 (2): 167-176.

  45. Treanor J. The cutter incident: how America’s first polio vaccine led to the growing vaccine crisis. Environ Health Perspect. 2006; 114 (9): A556.

  46. Trogen B, Oshinsky D, Caplan A. Adverse consequences of rushing a SARS-CoV-2 vaccine: implications for public trust. JAMA. 2020.

  47. Thompson MG, Pierse N, Sue Huang Q et al. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015. Vaccine. 2018; 36 (39): 5916-5925.

  48. Guo X, Guo Z, Duan C, Chen Z, Wang G, Lu Y et al. Long-term persistence of igg antibodies in SARS-CoV infected healthcare workers. medRxiv. 2020.




2020     |     www.medigraphic.com